Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
Titel:
Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer
Auteur:
Mok, Tony Ladrera, Guia Srimuninnimit, Vichien Sriuranpong, Virote Yu, Chong-Jen Thongprasert, Sumitra Sandoval-Tan, Jennifer Lee, Jin Soo Fuerte, Fatima Shames, David S. Klughammer, Barbara Truman, Matt Perez-Moreno, Pablo Wu, Yi-Long